Hot Semiconductor Stocks To Watch Right Now

Hot Semiconductor Stocks To Watch Right Now: Dialog Semiconductor PLC (DLG)

Dialog Semiconductor Plc creates integrated, mixed signal integrated circuits (ICs), optimized for personal portable, short-range wireless, lighting, display and automotive applications. The Company operates in three business segments: Mobile Systems, Automotive and Industrial, and Connectivity. The Mobile Systems segment includes its power management and audio chips especially designed to meet the needs of the wireless systems markets and a range of advanced driver technologies for low power display applications - from Passive Matrix Organic Light Emitting Diodes (PMOLEDs), to electronic paper and Micro Electro-Mechanical Systems (MEMS) displays. The Automotive and Industrial segment consists of products, which address the safety, management and control of electronic systems in cars and for industrial applications. The Connectivity segment includes activities, such as short-range wireless, digital cordless and voice over Internet protocol (VoIP) technology. Advisors' Opinion:

• [By Corinne Gretler]

  Colruyt SA jumped the most in almost a year after reporting earnings that beat estimates. Direct Line Insurance Group Plc (DLG), the U.K.'s biggest home and motor insurer, rallied 3.8 percent after saying it will cut jobs. GSW Immobilien AG, Berlin's largest residential landlord by market value, advanced 3.8 percent after saying both its chairman and chief executive officer will leave. Mining companies declined as metals fell.

• [By Jonathan Morgan]

  Dialog Semiconductor Plc (DLG) surged 6.5 percent to 12.55 euros, its highest price in two months, after Apple Inc. (AAPL), the company's biggest customer, reported fiscal third-quarter revenue and iPhone sales that beat analysts' estimates.

• [By Jonathan Morgan]

  Direct Line (DLG) dropped 2.5 percent to 212.6! pence. RBS sold 300 million shares at 210 pence apiece in its third sale of a stake in the insurance company, according to a statement. The bank, which is majority owned by the U.K. government, reduced its holding in Direct Line by 20 percent to 28.5 percent. RBS slipped 1.3 percent to 364.1 pence.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-semiconductor-stocks-to-watch-right-now-4.html

Top Industrial Conglomerate Stocks To Invest In Right Now

Top Industrial Conglomerate Stocks To Invest In Right Now: Siemens AG (SIEGY)

Siemens AG (Siemens), incorporated on August 28, 1996, is a globally operating technology company with core activities in the fields of energy, healthcare, industry and infrastructure. Siemens business activities focus on four sectors, Energy, Healthcare, Industry and Infrastructure & Cities. These sectors form four of Siemens reportable segments. In addition to the four sectors, Siemens has two additional reportable segments: Equity Investments and Siemens Financial Services (SFS). The Energy sector comprises four divisions: Power Generation, Wind Power, Power Transmission and Energy Service. The Healthcare Sector includes four divisions: Imaging & Therapy Systems, Clinical Products, Diagnostics and Customer Solutions; and one sector-led Business Unit, Audiology Solutions. The Industry sector consists of three divisions: Industry Automation, Drive Technologies and Customer Services; and one sector-led Business Unit, Metals Technologies. The Infrastructure & Cities sector consists of five divisions: Rail Systems, Mobility and Logistics, Low and Medium Voltage, Smart Grid, and Building Technologies. In July 2013 Siemens sold its stake in the Nokia Siemens Networks (NSN) joint venture to Nokia and OSRAM Licht AG was spun off from Siemens.

Industry

The Industry Sector offers a broad spectrum of products, solutions and services that help customers use resources and energy. The Sectors integrated technologies and holistic solutions primarily address industrial customers, particularly those in the process and manufacturing industries. The portfolio spans industry automation, industrial software, drive products and services, system integration, and solutions for industrial plant businesses. The Industry Sector consists of three Divisions: Industry Automation, Drive Technologies and Customer Services. The Sector also includes a sector-led Business Unit, Metals Technologies. In addition to its Se! ctor-level financial result s, Industry also breaks out financial results for the Indust! ry Automation Division and the Drive Technologies Division. The Industry Automation Division offers a range of standard products and system solutions for automation technologies used in the manufacturing and process industries. The Divisions offerings include automation systems and software, motor controls, machine-to- machine communication products, sensors, product and production lifecycle management products, and software for simulating and testing mechatronic systems. The Drive Technologies Division offers products and comprehensive systems across the entire drive train. These offerings are customized to the respective application and include numerical control systems, inverters, converters, motors (geared and gearless), drives and couplings. In addition, Drive Technologies supplies integrated automation systems for machine tools and production machines. The Division also offers integrated lifecycle solutions and services for industries such as shipbuilding, cement, m ining, and pulp and paper. The Customer Services Division offers a comprehensive portfolio of services and supports industrial customers.

Energy

The Energy Sector offers a spectrum of products, solutions and services for generating and transmitting power, and for extracting, converting and transporting oil and gas. The Fossil Power Generation Division offers products and solutions for fossil-based power generation. The Division concentrates on products and solutions for gas and steam turbines, turbo generators, heat recovery steam generators including control systems, with an emphasis on combined-cycle power plants. It also develops solutions for instrumentation and control systems for all types of power plants and for use in power generation. The Wind Power Division manufactures wind turbines for onshore and offshore applications, including both geared turbines and direct drive machines. The product portfolio is based! on four ! product platforms, two for each of the onshore and offshore applications. The Oil ! & Gas Div! ision has a comprehensive portfolio of rotating machinery (gas turbines, steam turbines, compressors with associated equipment) and electrical, instrumentation and telecommunication (EIT) solutions. The Power Transmission Division provides customers with turnkey power transmission solutions as well as discrete products, systems and related engineering and services. It covers high-voltage transmission solutions, power and distribution transformers, high-voltage switching and non-switching products and systems, and alternating and direct current transmission systems. The Energy Service Division offers comprehensive services for products, solutions and technologies, covering performance enhancements, maintenance services, customer trainings and consulting services for the Divisions Fossil Power Generation, Wind Power and Oil & Gas. The Wind Power Division is active in both the onshore and the offshore market segments globally. Power Transmission Division is expanding infrastruc ture in emerging countries, equipment replacement and modernization in mature economies, and integration of renewable energies.

Healthcare

The Healthcare Sector offers customers a comprehensive portfolio of medical solutions across the treatment chain-ranging from medical imaging to in-vitro diagnostics to interventional systems and clinical information technology systems-all from a single source. In addition, the Sector provides technical maintenance, professional and consulting services, and, together with Financial Services (SFS), financing to assist customers in purchasing the Sectors products. The Healthcare Sector includes four Divisions: Imaging & Therapy Systems, Clinical Products, Diagnostics and Customer Solutions. The Sector also includes one sector-led Business Unit, Audiology Solutions. In addition to its Sector-level financial results, Healthcare also separately breaks out financial results for ! the Diagn! ostics Division.

The Imaging & Therapy Systems Division provides large-scale! medical ! devices for diagnostic imaging and for image-guided therapies. Imaging equipment includes computed tomographs, magnetic resonance imaging equipment, angiography systems for diagnostics, and positron emission tomography. The Clinical Products Division mainly comprises the business with ultrasound and X-ray equipment including mammography. The Diagnostics Division offers products and services in the area of in-vitro diagnostics. The Divisions product portfolio represents a comprehensive range of diagnostic testing systems and consumables, including offerings for clinical chemistry and immunodiagnostics, molecular diagnostics, hematology, hemostasis, microbiology, point-of-care testing and clinical laboratory automation solutions. The Customer Solutions Division provides healthcare information technology (HIT) systems. It is responsible for the Sectors service business and customer relationship management on a global level.

Equity Investments

The Equity Investments comprises equity stakes held by Siemens that are accounted for by the equity method, at cost or as current available-for-sale financial assets and for strategic reasons are not allocated to a Sector, SFS, Centrally managed portfolio activities, Siemens Real Estate (SRE), Corporate items or Corporate Treasury. Its main investments within Equity Investments are its stake of 50% in BSH Bosch and Siemens Hausgerate GmbH (BSH), its stake of 17% in OSRAM Licht AG (OSRAM) as well as its 49% stake in Enterprise Networks Holdings B.V. (EN).

Financial Services

Financial Services provides a variety of financial services and products to other Siemens units and their customers and to third parties. SFS has three strategic pillars: supporting Siemens units with finance solutions for their customers, managing financial risks of Siemens and offering third-party finance services and products. SFS business! can be d! ivided into capital business a nd fee business. The Commercial Finance Business Unit offers! a compre! hensive range of solutions for equipment financing, leasing, rental and related financing for equipment supplied by Siemens or third-party providers. The Venture Capital Business Segments main task, together with Siemens Sectors, is to identify and finance young companies worldwide. The Treasury Business Unit operates the global Corporate Treasury of the Siemens Group, with SFS employees thereby managing liquidity, cash and financial risks (interest, foreign exchange, commodities) on behalf of Corporate Treasury. The Financing & Investment Management Business Unit manages fee-based receivables and offers investment management services. The Insurance Business Unit acts primarily as an insurance broker for Siemens and external customers.

Infrastructure & Cities

The Infrastructure & Cities Sector offers a range of technologies for the sustainability of metropolitan centers and urban infrastructures worldwide, such as integrated mobility soluti ons, building and security systems, power distribution equipment, smart grid applications and low and medium-voltage products. The Sector consists of five Divisions: Rail Systems; Mobility and Logistics; Low and Medium Voltage; Smart Grid; and Building Technologies. The Rail Systems Division comprises Siemens rail vehicle business, encompassing the entire spectrum of rolling stock-including high-speed trains, commuter trains, passenger coaches, metros, people movers, light rail vehicles, locomotives, bogies, traction systems and rail-related services. The Mobility and Logistics Division primarily provides products, solutions (including IT solutions) and services for rail transportation operating systems, such as central control systems, interlockings and automated controls. The Division also provides offerings for road traffic, including traffic detection, information and guidance systems.

Advisors' Opinion:

• [By ! Garrett C! ook]

  Dresser-Rand Group (NYSE: DRC) shares were also up, gaining 2.60 percent to $81.99 after Siemens AG (OTC: SIEGY) announced its plans to acquire Dresser-Rand for $7.6 billion.

• [By Garrett Cook]

  Shares of Dresser-Rand Group (NYSE: DRC) got a boost, shooting up 10.24 percent to $80.50 on report of a $85 per share bid from Siemens (OTC: SIEGY).

• [By Luke Jacobi]

  Dresser-Rand Group (NYSE: DRC) shares were also up, gaining 2.6 percent to $81.97 after Siemens AG (OTC: SIEGY) announced its plans to acquire Dresser-Rand for $7.6 billion.

• [By Luke Jacobi]

  Shares of Dresser-Rand Group (NYSE: DRC) got a boost, shooting up 9.4 percent to $79.91 on report of a $85 per share bid from Siemens (OTC: SIEGY).

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-industrial-conglomerate-stocks-to-invest-in-right-now-2.html

The Gap’s Gap: Share’s Fall 3% on Disappointing Sales, Susquehanna Downgrade

The Gap (GPS) reported disappointing sales yesterday–disappointing enough that investors ignored its profit projections to force the stock lower today.

Bloomberg

The Wall Street Journal has the details:

[For] the four weeks ended Aug. 3, same-store sales rose 1%, falling short of the 1.6% consensus view. Gap stores posted a 7% rise when 1.7% growth was expected, while Banana Republic’s same-store sales declined 1%, compared to expectations for a 1.6% decline. Old Navy recorded a 5% decline in same-store sales, missing expectations for 2.4% growth…

Best Shipping Stocks To Invest In Right Now

For the quarter ended Aug. 3, the retailer said it expects per-share earnings of 62 cents to 64 cents, topping the 59 cents estimated by analysts polled by Thomson Reuters. Net sales for the quarter rose 8% to $3.87 billion, also topping analysts’ projections of $3.8 billion.

As a result of the announcement, the Gap’s shares have dropped 3.4% to $43.96, after opening down 1.8%, far cry from the big gain following its June report.

Many analysts were far more positive than the market, however. Janney Capital Market’s Adrienne Tennant and Gabriella Carbone, for instance, blame the sputtering sales on difficult comparisons. They write:

…we continue to remain encouraged by solid traffic trends seen across all divisions and expect sustainable positive comps going forward. A key initiative for 2013 is to drive increased revenues through new brands, channels, and geographies, such as Athleta, Gap China, Old Navy Japan, franchises, and global outlets. GPS also has planned to start franchising Old Navy in 2014 in key international markets and are exploring the opportunities to add company-operated Old Navy and Banana Republic stores in China. We believe the new global brand management structure of the business will continue to build upon overall brand strength, help attain greater speed and efficiencies, as well as fuel future long term growth. Overall, we continue to believe the company will benefit from ongoing momentum at all three divisions.

Lazard’s Jennifer Davis, meanwhile, believes the Gap will be able to “maintain sales momentum though 2H despite more difficult compares.” She raised her price target to $52 from $50.

Even a downgrade from Susquehanna’s Thomas Filandro–he cut the stock to Neutral from Positive–was done executed because the stock had gotten too expensive. Filandro writes:

Another well executed quarter for GPS. Although we are once again raising our EPS projections and increasing our price target, we are downgrading to Neutral from Positive based entirely on valuation. Since November 2011, GPS shares have appreciated 137%. We applaud management’s execution of the business, distribution of excess cash to shareholders and focus on building an omni-channel global presence. We are raising our 12- month price objective to $49.

Sterne Agee’s Ike Boruchow and Tom Nikic, however, worry that margins might have peaked. They write:

Team Inc in Nuclear Plant Inspection - Analyst Blog

Quest Integrity Group, a business group of Team Inc. (TISI), recently introduced a new animation specifically designed to inspect and access buried or inaccessible piping in nuclear facilities. The animation will use ultrasonic-based intelligent pigging technology named HYDRA.

HYDRA has unique features which facilitate inspection of nuclear pipes buried inside or even under concrete structures. Its condensed lightweight feature allows it to be easily transported into and around a plant. Additionally, its bi-directional feature requires the animation to be launched from a single location.

With such innovative features, the tool can easily navigate through complex piping circuits for inspecting the exterior and interior surface. HYDRA can also record damages like pitting, corrosion or erosion and hidden deformations such as denting, ovality, swelling or bulging on the wall.

The product is expected to offer a cost-effective in-line inspection of inaccessible pipes, assisting nuclear plant managers to comply with regulatory requirements for inspection. In addition, HYDRA technology ensures piping integrity and minimizes operational and safety risks.

Headquartered in Seattle, Quest provides advanced technology-enabled solutions to diverse companies in refining, chemical, pipeline, syngas and power industries to reduce operational risks and improve profit margins.

Quest is one of the newly-formed operating segments of Team, Inc., the other two being Inspection and Heat Treating Services, and Mechanical Services.

Team Inc. is a leading industrial services company which offers specialized services in fields like refining, petrochemical, power, pipeline, and other heavy industrial industries.

Team Inc. currently carries a Zacks Rank #5 (Sell). Better stocks within the business services sector worth mentioning are Portfolio Recovery Associates Inc. (PRAA), ABM Industries Incorporated (ABM) and Rollins Inc. (ROL). While Portfolio Recovery and ABM Industries ea! ch holds a Zacks Rank #1 (Strong Buy), Rollins carries a Zacks Rank #2 (Buy).

Top 5 Mid Cap Companies To Watch For 2016

Top 5 Mid Cap Companies To Watch For 2016: Fibria Celulose SA (FBR)

Fibria Celulose S.A. (Fibria), formerly Votorantim Celulose e Papel S.A., incorporated on July 25, 1941, is a producer of market pulp. During the year ended December 31, 2010, Fibria produced 5,054 kilotons of eucalyptus pulp (including 50.0% of the pulp production of Veracel). The Company also produces coated and uncoated paper, carbonless paper and thermal paper at its Piracicaba paper mill, located in the State of Sao Paulo with an annual production capacity of 190 kilotons. During 2010, it produced 115 kilotons of paper products and recorded consolidated net revenues. Fibria produces bleached eucalyptus kraft pulp at three pulp mills, the Aracruz pulp mill located in the State of Espirito Santo, which has an annual production capacity of 2.3 million tons; the Tres Lagoas pulp mill located in the State of Mato Grosso do Sul, which has an annual production capacity of 1.3 million tons, and the Jacarei pulp mill located in the State of Sao Paulo, which has an annual produ ction capacity of 1.1 million tons. The Company has a 50% interest in Veracel, which owns and operates a pulp mill in the municipality of Eunapolis, State of Bahia, with an annual production capacity of 1.1 million tons.

Pulp

Fibria produces bleached eucalyptus kraft pulp from planted eucalyptus trees. Bleached eucalyptus kraft pulp is a range of hardwood pulp. Eucalyptus is a hardwood tree, and its pulp has short fibers and is generally suited to manufacturing tissue, coated and uncoated printing and writing paper and coated packaging boards. Short fibers are optimal for manufacturing wood-free paper with good printability, smoothness, brightness and uniformity. Market pulp is the pulp sold to producers of paper products. Kraft pulp is pulp produced in a chemical process using sulphate. During 2010, it produced 5,054 kilotons of pulp (including 50.0% of the pulp production of Veracel).

Paper

During 2010! , Fibria produced 11 5 kilotons of paper. The Company produced coated printing and writing paper, which is a coated woodfree paper used for promotional materials, folders, internal sheets and cover of magazines, books, tabloids, inserts and mailing; uncoated printing and writing paper, which is a uncoated woodfree paper in reels and sheets; carbonless paper, which is used to produce multi-copy forms, POS, invoices and other applications in place of traditional carbon paper, and thermal paper, which is traditionally used in fax machines; POS, bar code labels, toll tickets, water and gas bills and receipts for automated teller machines (ATMs) and credit card machines. It manufactures thermal paper products with technology licensed byOji Paper Co., Ltd (Oji Paper).

The Company competes with APRIL, Arauco, APP, Georgia Pacific, CMPC, Sodra, Stora Enso, Weyerhaeuser and Suzano.

Advisors' Opinion:

• [By Seth Jayson]

  Fibria Celulose (NYSE: FBR  ) reported earnings on July 24. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Fibria Celulose met expectations on revenues and missed expectations on earnings per share.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-mid-cap-companies-to-watch-for-2016.html

Best Medical Stocks To Watch For 2016

Best Medical Stocks To Watch For 2016: Acceleron Pharma Inc (XLRN)

Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Companys research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. By coupling its discovery and development expertise, including its knowledge of the TGF-b superfamily, with its internal protein engineering and manufacturing capabilities, it has built a productive research and development platform that has generated clinical and preclinical protein therapeutic candidates with mechanisms of action.

The Company focuses on discovering and developing protein therapeutics that target a group of approximately 30 secreted proteins, or ligands, that are collectively referred to as the TGF-b superfamily. These ligands bind to subsets of 12 different receptors on the surface of cells, triggering intra-cellular changes in gene expression that guide cell growth and differentiation. The TGF-b superfamily ligands and their receptors represent an under-explored and diverse set of drug targets with the potential to yield therapeutics that modulate the growth and repair of diseased cells and tissues.

The Company has three internally discovered protein therapeutic candidates that are being studied in 12 ongoing Phase 2 clinical trials, focused on cancer and rare diseases. The Companys two advanced protein therapeutic candidates, sotatercept and ACE-536, promote red blood cell production through a novel mechanism. Together with its collaboration partner, Celgene Corporation, the Company is developing sotatercept and ACE-536 to treat anemia and associated complications in patients with b-thalassemia and myelodysplastic syndromes (MDS). ! These red blo od cell disorders are generally unresponsive to approved drugs. The Companys third clinical stage protein therapeutic candidate, dalantercept, is designed to inhibit blood vessel formation through a mechanism that is distinct from, and potentially synergistic with, the dominant class of cancer drugs that inhibit blood vessel formation, the vascular endothelial growth factor (VEGF) pathway inhibitors. The Company is developing dalantercept primarily for use in combination with these products to produce better outcomes for cancer patients.

The Company and Celgene have conducted six human clinical trials with sotatercept in over 160 healthy volunteers and cancer patients. The Company has conducted one clinical trial with ACE-536 in healthy volunteers. In these studies, both sotatercept and ACE-536 caused a dose-dependent increase in the number of red blood cells. Based on these results, the Company and Celgene have initiated Phase II clinical trials with each of these protein therapeutic candidates in b-thalassemia and MDS. In the ongoing trial of sotatercept in patients with b-thalassemia, the Company has observed encouraging, dose-dependent increases in hemoglobin in a subset of patients at the two lowest dose levels.

Sotatercept is a soluble receptor fusion protein consisting of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc domain of human IgG1. Sotatercept acts as a protein trap for TGF-b superfamily ligands that signal through the ActRIIA receptor. Sotatercept has increased red blood cells in multiple clinical trials. ACE-536 is a soluble receptor fusion protein consisting of a modified extracellular domain of the activin receptor type IIB (ActRIIB) linked to the Fc domain of human IgG1.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Shares of Acceleron Pharma (NASDAQ: XLRN) got a boost, shooting up 16.74 percent to $39.54 after Form 8-K for Acceleron Pharma showed that Celgene (NASDAQ: CELG) will! buy 1.1 ! million shares for $47.15 million.

• [By John Udovich]

  Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.

• [By Monica Gerson]

  Breaking news

  Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.

  Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By John Udovich]

  The biotech sector has been pretty exciting this yearwith small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investorswhile Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have justset term sheets for their upcoming IPOs. Just consider all of the following recent news! :

  source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-medical-stocks-to-watch-for-2016.html

Here's Why Universal Display Plunged Today

Universal Display (NASDAQ: OLED  ) shareholders were left shaking their heads Monday after the stock plummeted as much as 12% during intraday trading. Shares recovered to a 4.3% loss by the end of the day.

The company didn't report earnings early; it's still all set to announce second-quarter results next Thursday, August 8. In fact, there were no new press releases on the OLED technologist's website this morning, and the silence on Universal Display's news feeds seemed absolutely deafening as the selling continued to accelerate.

So what happened?
In a word: Samsung.

Specifically, investors panicked after a Bloomberg report surfaced saying the Korean electronics giant was close to announcing a deal to acquire German OLED specialist Novaled AG.

In addition, Samsung also released its audited second-quarter earnings results this weekend, which showed the company's growth is slowing largely thanks to disappointing sales of its flagship Galaxy S4 smartphone.

Image Source: Samsung.

Of course, the Galaxy S4's massive 5-inch, full-HD AMOLED screen is powered by Universal Display's technology, and it's no mystery Samsung has long stood alone as Universal Display's single largest customer. In fact, according to Universal's most recent annual report, Samsung Display accounted for a whopping 68% of the company's total revenue in last year.

And considering Samsung's mobile devices currently represent the only technology segment to utilize OLED in any significant capacity to date, you can't blame Mr. Market for being skittish with regard to Universal Display's prospects going forward.

Here's the problem with that thinking
However, I think there are several reasons this train of thought is shortsighted, at best.

First, we need to remember Universal Display and Novaled have long worked in a jointly cooperative fashion with one another for nearly a decade to improve the efficiency of OLED materials, and in the process have continuously supplied complementary -- not competitive -- materials to larger electronics manufacturers like Samsung.

In fact, analysts from both Wedbush and Oppenheimer quickly chimed in this afternoon to say as much, helping the stock recover the majority of its losses to close down just above 4% for the day.

Curiously enough, for those of you keeping track, today's sell-off was also disturbingly similar to the 13% plunge Universal Display endured in February after another analyst voiced concerns that fellow OLED supplier Nippon Steel was also supplying green OLED materials to Samsung. Once again, however, and as I pointed out at the time, Nippon Steel was just another one of UDC's longtime partners and represents little threat to its leadership in the OLED market.

10 Best Financial Stocks To Own Right Now

Second, with regard to Samsung's earnings report, it's also important to remember OLED is still in the very early stages of development and Samsung isn't the only game in town.

LG Display (NYSE: LPL  ) , for example, announced back in April that it will dedicate more than 50% of its 2014 capital expenditures not only to improving its utilization of OLED technology in exciting new products -- including flexible and transparent displays -- but also to building out its infrastructure to support mass production of the OLED displays.

In addition, Samsung itself stated in its earnings release that one of its bright spots was "improved earnings led by OLED panel shipment growth for premium smartphones," so you can bet the company won't be abandoning the technology anytime soon. In fact, Samsung's release went on to state the company "expect[s] [OLED] smartphone panel demand growth to continue" as it expands "line-ups featuring various sizes and high resolution."

What's more, while mobile devices have largely been responsible for filling Universal Display's coffers so far, other technologies including large-screen OLED televisions from Samsung, LG, Sony, and Panasonic are finally beginning to make headway in consumer markets, so that should meaningfully contribute to revenue as economies of scale enable lower prices. In addition, over the next few years, Universal Display investors can also look forward to growth from increased adoption of new OLED lighting solutions, encapsulation tech, and any other incredible new OLED gadgets that might show up along the way.

As a result, I remain convinced Samsung's current weakness -- which could just as easily prove temporary, anyway -- has no significant long-term negative effects on Universal Display's business.

So don't panic, Universal Display shareholders: Your company is doing just fine.

It's incredible to think just how much of our digital and technological lives are almost entirely shaped by just a handful of companies like Samsung. Find out "Who Will Win the War Between the 5 Biggest Tech Stocks?" in The Motley Fool's latest free report, which details the knock-down, drag-out battle being waged by the five kings of tech. Click here to keep reading.

Do you think there's another reason shares of Universal Display are suffering right now? Feel free to weigh in using the comments section below.

Top 5 Stocks To Buy Right Now

Top 5 Stocks To Buy Right Now: Cadus Corp (KDUS)

Cadus Corporation (Cadus), incorporated in January 23, 1992, has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all patents, patent applications, know how, licenses and drug discovery technologies of the Company. The Company maintains all its strains, as well as a biological database that catalogues its collection of cells, cell lines, yeast strains and genetic engineering tools. This database has approximately 30,000 entries, which include the phenotype and the genotype of the cell or yeast strain and its storage site. As of December 31, 2011, the Company had no internal or external drug discovery operations.

Yeast

The Company has developed technologies based on yeast that are useful in identifying drug discovery candidates targeted at G Protein-coupled receptors. Yeast is a single-celled microorganism that is used to make bread, beer and wine. Both yeast and human cells consist of a membrane, an intracellular r egion and a nucleus containing genes. The genes in yeast express proteins, including cell-surface receptors, such as G Protein-coupled receptors and signaling molecules, such as protein kinases, that are similar to human proteins.

Hybrid Yeast Cells

The Company developed a technology to insert human genes into yeast cells to create hybrid yeast cells. Its scientists created hybrid yeast cells by replacing yeast G Protein-coupled receptor genes and certain signaling molecules with their human equivalents. As a result, these hybrid yeast cells express a human G Protein-coupled receptor and a portion of its signaling pathway. These hybrid yeast cells can be used to identify those compounds that act as agonists or antagonists to that receptor or a molecule that is in its signaling pathway. The Company designed and developed more than 25 thousand genetically different yeast st! rains that can be used to build hybrid yeast cells (the Yeast System).

The Company competes with Glaxo Smith Kline, Plc.

Advisors' Opinion:

• [By Geoff Gannon] cash producing business like ADDvantage (AEY) that happens to be overcapitalized. I'd much rather own a business with real earnings rather than wait for something to happen with a pile of cash.

  My question is this: How cheap is cheap enough? Clearly (to me), George Risk (RSKIA) is cheap at or even just above book value. It's a darn good business so I'm getting high quality assets and earnings power. That gets less clear when looking at lower quality businesses.

  For example:

  Solitron (SODI) sells at 74% of NCAV, has decent z- and f-scores, a FCF margin of 5.3% and an ROA of 12%.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-stocks-to-buy-right-now-3.html

Best Industrial Disributor Stocks For 2015

History never repeats but often rhymes. So when it comes to the demise of bull markets, we can, to borrow the immortal line of Captain Renault in Casablanca, round up the usual suspects. Often, the factors below are found at the scene of the crime (the start of a bear market). None appears to be an imminent threat yet, but it pays to be on the lookout for these bear-market bellwethers.

SEE ALSO: 7 Cheap Stocks the Market Left Behind

1. Higher inflation

Spiraling prices reduce consumer buying power, which accounts for some 70% of U.S. economic activity. Inflation also whittles the value of financial assets. Think back to the mid 1970s, when oil (and wheat) price shocks bumped consumer prices to double digits in 1974. Inflation vacuumed money out of financial assets and into gold, real estate and other hard assets, and Standard & Poor�� 500-stock index lost 48% of its value between January 1973 and October 1974. (All figures for bear-market declines exclude dividends.)

Top 5 Oil Service Stocks To Own For 2016: Nuveen Equity Premium Opportunity Fund (JSN)

Nuveen Equity Premium Opportunity Fund (the Fund) is a diversified, closed-end management investment company. The Fund primarily invests in a diversified equity portfolio that seeks to substantially replicate price movements of either the Standard & Poor's 500 Stock Index or a weighted average of the Standard & Poor's 500 Stock Index and the NASDAQ-100 Index and is designed to support the Funds' index option strategies. Nuveen Asset Management is the adviser of the Fund. The Adviser has engaged Gateway Investment Advisers, L.P. (Gateway/Sub-Adviser) as Sub-Adviser to provide discretionary investment advisory services.

The initial target weighting of the Fund's equity portfolio in seeking to replicate the weighted average price movements of the market indexes will be 75% of the Standard & Poor's 500 Stock Index and 25% of the NASDAQ-100 Index. Over time, these percentage weightings may vary as the result of relative changes in each index. The Fund intends to pursue its investment objectives by utilizing an index option strategy of selling index call options and buying index put options, each on the Standard & Poor's 500 Stock Index and the NASDAQ-100 Index.

The Fund's comparative benchmark performance is a blended return consisting of 75% of the return of the S&P 500 Index, and 25% of the return of the NASDAQ-100 Index, which includes 100 of the largest domestic and international non-financial companies listed on The NASDAQ Stock Market based on market capitalization. The NASDAQ-100 Index reflects companies across major industry groups, including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology.

Advisors' Opinion:

• [By Robert Hsu]

  Here are four to consider:

  PowerShares S&P 500 BuyWrite ETF (PBP), yielding 4.09%
  
  Madison/Claymore Covered Call & Equity Strategy (MCN), yielding 8.94%
  
  Nuveen Equity Premium Opportunity Fund (JSN), yielding 9.19%
  
  BlackRock Enhanced Dividend Achievers (BDJ), yielding 7.39%
  
  

  The yield on these funds is very attractive. Even more attractive is the fact that many buy-write funds actually are selling at a discount to their net asset value.

• [By Robert Hsu]
  Name Type of Security� Recommendation� Kinder Morgan Energy Partners L.P. (NYSE: KMP) � MLP August 15, 2013� TeeKay LNG Partners L.P.� (NYSE: TGP) � MLP September 16, 2013� PowerShares S&P 500 BuyWrite Portfol ETF� (NYSE Arca: PBP)� Buy-Write ETF September 30, 2013� Madison Covered Call Equity Strtgy Fd (NYSE: MCN)� Buy-Write ETF September 30, 2013� Nuveen Equity Premium Opportunity Fund (NYSE: JSN)� Buy-Write ETF September 30, 2013� BlackRockEnhanced Dividend Achievers Tr (NYSE: BDJ)� Buy-Write ETF September 30, 2013� Vornado Realty Trust � (NYSE: VNO)� Real Estate
  Investment
  Trust September 26, 2013�
  
  

  Robert Hsu is the editor of Permanent Wealth Investor and a former hedge fund portfolio manager at Wall Street powerhouse Goldman Sachs. He retired from Goldman at age 31. He since has come out of retirement to establish and preside over his money management firm, Absolute Return Capital Advisors. His retirement experience has given him his current mission: helping investors like you achieve their goal of comfortable retirement through profitable income strategies.

Best Industrial Disributor Stocks For 2015: Aethlon Medical Inc (AEMD)

Aethlon Medical, Inc. (Aethlon), incorporated on April 17, 1991, is a developmental-stage company. The Company is focused on creating medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.

The Company's Aethlon ADAPT (Adaptive Dialysis-Like Affinity Platform Technology) system is a revenue-stage technology platform that provides the basis for a new class of devices that provide rapid, selective removal of disease promoting particles from the entire circulatory system. The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under the Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.

The Aethlon Hemopurifier

The Company's Hemopurifier is a medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation. Under the feasibility study protocol, the Company will enroll ten end-stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. In addition to augmenting the early viral kinetic response to SOC, the Company's Hemopurifier provides a candidate solution for viral rebound patients who traditionally are forced to discontinue therapy at the point HCV establishes resistance to drug regimens. Additionally, the Company's Hemopurifier represents a therapeutic strategy to address the population of HCV-infected dialysis patients for which SOC and all-antiviral strategies may be contraindicated or not cleared.

In design, the Company's Hemopurifier consists of the affinity lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of advanced plasma membrane technology. The design allows for extracorporeal therapeutic delivery to occur on standard CRRT and dialysis instruments alre! ady located in hospitals and clinics worldwide. The mechanism of the Hemopurifier to rapidly eliminate a broad-spectrum disease targets is based on GNA�� ability to selectively bind high mannose signatures that are abundant on the surface of cancer-secreted exosomes and glycoproteins that reside on the outer membrane of infectious viral pathogens. The Company has also established a compassionate-use treatment program at the Medanta Medicity Institute in India that provides treatment access to HCV-infected individuals.

The Company's Hemopurifier has also been discovered to capture tumor-secreted exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. In addition to treating HCV-infected individuals, the Company has conducted a single proof of principal treatment study related to the treatment of HIV. In the study, Hemopurifier therapy reduced viral load by 93% in an HIV-AIDS infected individual without the administration of antiviral drug therapy. The study protocol provided for 12 Hemopurifier treatments, each four hours in duration, that were administered over the course of one month. Researchers at a university have since discovered that the Hemopurifier is able to capture exosomes that transport NEF protein, which is known to suppress the immune response in HIV-infected individuals.

The Company has been assigned all rights and title to and interests in an invention and related worldwide patent rights for a method to treat cancer under an assignment agreement with the London Health Science Center Research, Inc. (LHSCRI) The agreement provides that the Company is responsible for paying certain patent application and filing costs as well as a 2% royalty on any future net sales. The Company has als! o exercis! ed an option to license a pending patent entitled, Method to Inhibit Proliferation and Growth of Metastases from The Trustees of Boston University. The license provides a development strategy for new cancer therapies by uniting drug agents that inhibit the spread of cancer-related metastases with filtration techniques already in the Aethlon Hemopurifier(R). The resulting devices would inhibit tumor growth by reducing the presence of circulating growth factors without interfering with surgical wound healing or the recovery of tissue injured by radiation therapy.

The Company competes with Asahi Kasei Kurary Medical.

Advisors' Opinion:

• [By James E. Brumley]

  Stocks as a whole haven't gotten the new year off on the best foot, but that's not to say every equity out there is in trouble. Indeed, some small cap stocks may actually be doing well - and poised to do well for a while - specifically because larger companies are seeing their stocks struggle. To that end, traders looking for a bullish bright spot to start the new year may want to take a closer look at Amedica Corporation (NASDAQ:AMDA), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and Aethlon Medical, Inc. (OTCMKTS:AEMD).

Best Industrial Disributor Stocks For 2015: Japan Petroleum Exploration Co Ltd (JPTXF)

Japan Petroleum Exploration Co., Ltd. is a company principally involved in the energy business. The Company operates in four geological segments. The Japan segment involves in the production, purchase and sale of crude oil and natural gas in Japan, the contracting of drilling and refurbishment works, mud logging works, research works, geophysical exploration works, the provision of pipeline maintenance services and security guard services, the purchase and sale of petroleum products, the transportation of petroleum and natural gas products, as well as real estate management business. The North America segment involves in the exploration and development of crude oil and natural gas in North America. The Middle East segment involves in the development of crude oil and natural gas. The Others segment involves in the exploration, development and production of crude oil and natural gas in Southeast Asia. As of March 31, 2013, the Company had 26 subsidiaries and 17 associated companies. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)

Best Industrial Disributor Stocks For 2015: Atlatsa Resources Corp (ATL)

Atlatsa Resources Corporation is engaged in mining, exploration and development of mineral deposits located in the Bushveld Igneous Complex (BIC), South Africa. The principal business activity is the mining and exploration of platinum group metals (PGM), through its mineral property interests. The Company�� subsidiaries include N1C Resources Incorporation, Anooraq Minera Mexicana, N2C Resources Incorporation, Plateau Resources Proprietary Limited, Bokoni Holdings Proprietary Limited, Bokoni Mines Proprietary Limited, Boikgantsho Proprietary Limited, Kwanda Proprietary Limited, Ga-Phasha Proprietary Limited, Middlepunt Hill Management Services (Proprietary) Limited and Lebowa Platinum Mine Limited. Advisors' Opinion:

• [By Roberto Pedone]

  Another stock that's starting to move within range of triggering a big breakout trade is Atlatsa Resources (ATL), which engages in the mining, exploration and development of platinum group metals properties located in the Bushveld Igneous Complex in South Africa. This stock has been on fire so far in 2013, with shares up a whopping 198%.

  If you take a look at the chart for Atlatsa Resources, you'll notice that this stock has been uptrending strong for the last two months and change, with shares soaring higher from its low of 28 cents per share to its intraday high of 46 cents per share. During that uptrend, shares of ATL have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of ATL have now started to take out some near-term overhead resistance levels at 43 cents to 44 cents per share. That move is quickly pushing shares of ATL within range of triggering another big breakout trade.

  Market players should now look for long-biased trades in ATL if it manages to break out above its 52-week high at 50 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 170,178 shares. If that breakout hits soon, then ATL will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at 63 cents to 73 cents per share, or even 80 cents per share.

  Traders can look to buy ATL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of 39 cents per share, or near more support at 37 cents per share. One can also buy ATL off strength once it clears its 52-week high at 50 cents with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Industrial Disributor Stocks For 2015: ProShares Ultra Dow30 (DDM)

ProShares Ultra Dow30 (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones Industrial Average (DJIA). The DJIA is a price-weighted index maintained by editors of The Wall Street Journal. The Index includes 30 large-cap, blue-chip United States stocks, excluding utility and transportation companies. Components are selected through a discretionary process with no predetermined criteria except that components should be established United States companies. The DJIA is not limited to traditionally defined industrial stocks, instead, the Index serves as a measure of the entire United States market, covering such diverse industries as financial services, technology, retail, entertainment and consumer goods. The Fund takes positions in securities and/or financial instruments that, in combination, should have similar daily return characteristics as 200% of the daily return of the Index. Its investment advisor is ProShare Advisors LLC. Advisors' Opinion:

• [By Victor Selva]

  In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.

• [By Damian Illia]

  In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.

• [By Damian Illia]

  In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.

• [By Victor Selva]

  In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.

Best Industrial Disributor Stocks For 2015: SurModics Inc.(SRDX)

SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, and urology markets. It also provides a range of drug delivery technologies for injectable therapeutics, including microparticles, nanoparticles, and implants addressing a range of clinical applications, such as ophthalmology, oncology, dermatology, and neurology. In addition, the company provides in vitro diagnostic component products and technologies comprising microarray slide technologies, protein stabilization reagents, substrates, polymers and reagent chemicals, and antigens for diagnostic test kits and biomedical research applications. SurModics, Inc. market s its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SurModics (Nasdaq: SRDX  ) , whose recent revenue and earnings are plotted below.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SurModics (Nasdaq: SRDX  ) , whose recent revenue and earnings are plotted below.

Best European Stocks To Watch For 2016

Best European Stocks To Watch For 2016: BP p.l.c.(BP)

BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors' Opinion:

• [By Dan Caplinger]

  Time to diversify?
  For international investors, weak stock markets might well offer a great opportunity. As stocks in the U.S. appear inc! reasingly overpriced, beaten-down international stocks are a better value. For instance, European energy stocks BP (NYSE: BP  ) and Total (NYSE: TOT  ) haven't done as well as their U.S. counterparts, even though they both have similar global exposure to energy assets around the world. When you think about investing, don't ignore the Global Dow, despite the Dow Industrials' stronger performance recently.

• [By Royston Wild]

  Today I am looking atBP (LSE: BP  ) (NYSE: BP  ) to see how it measures up.

  What are BP's earnings expected to do?

• [By Matt DiLallo]

  Contango can also affect a company like LINN Energy (NASDAQ: LINE  ) which seeks to hedge all of its production for the long term. A good example of this can be seen last year when LINN Energybought the Jonah Field from BP (NYSE: BP  ) . Upon closing the deal, LINN hedged 100% of the expected oil and natural gas production through 2017. If the market were in contango at the time it could have had an impact on the future profits LINN expects to produce from that asset. It would mean that production sold just after closing would have netted a higher sale price than oil and gas that won't be produced until 2017. That's one reason why LINN had been using puts to hedge its production; it wanted to keep some of that upside.

• [By M. Joy Hayes, Joy]

  Thus, a failure to protect these employees arguably puts Exxon at a competitive disadvantage against companies like Chevron (NYSE: CVX  ) , Shell Oil (NYSE: RDS-A  ) , and BP (NYSE: BP  ) which, according to the Human Rights Campaign, all offer better protections and benefits for LGBT employees.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-european-stocks-to-watch-for-2016.html

Why Approach Resources Inc.'s Shares Dropped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Approach Resources (NASDAQ: AREX  ) dropped 10% today after the company released earnings.

So what: Sales rose 33.8% from a year ago, to $44.2 million, and the company swung to a profit of $495,000, or $0.01 per share. After adjusting for one-time items, the company made a profit of $0.07 per share, in line with estimates. 

Management did lower 2013 production estimates from 3.6 MMBoe, to 3.4 MMBoe, due to downtime at a third-party NGL fractionation facility. This is where the real disappointment came today.

Now what: Management still expects to grow production 40% next year by drilling 70 more horizontal wells. I'm also encouraged by a 20% decline in the cost of each well. This wasn't a great quarter, but the plant shutdown is a one-time event, so I don't think it's a reason to panic. Investors are getting a nice discount today, and if operational improvement continues, next year, the stock has room to run higher.

Three energy stocks to buy
The energy industry is changing rapidly, especially here in the U.S. The Motley Fool is offering a comprehensive look at three energy companies set to soar during this transformation in the energy industry. Find out what they are in our special free report, "3 Stocks for the American Energy Bonanza." Don't miss out on this timely opportunity; click here to access your report -- it's absolutely free. 

Hot Life Sciences Companies To Invest In 2016

Hot Life Sciences Companies To Invest In 2016: News Corporation(NWSA)

News Corporation operates as a diversified media company worldwide. Its Cable Network Programming segment produces and licenses news, business news, sports, general entertainment, and movie programming for distribution through cable television systems and direct broadcast satellite operators primarily in the United States, Latin America, Europe, and Asia. The company?s Filmed Entertainment segment produces and acquires live-action and animated motion pictures for distribution and licensing in entertainment media, as well as produces and licenses television programming worldwide. Its Television segment operates 27 broadcast television stations in the United States. The company?s Direct Broadcast Satellite Television segment distributes programming services via satellite and broadband directly to subscribers in Italy. Its Publishing segment provides newspapers and information services, such as publishing national newspapers in the United Kingdom, approximately 146 newspapers in Australia, and a metropolitan and a national newspaper in the United States; book publishing services, including the publishing of English language books worldwide; and integrated marketing services comprising the publishing of free-standing inserts, which are marketing booklets containing coupons, rebates, and other consumer offers, as well as provides in-store marketing products and services, primarily to consumer packaged goods manufacturers in the United States and Canada. The company also sells advertising, sponsorships, and subscription services on the company?s various digital media properties and outdoor advertising space on various media primarily in Russia and eastern Europe; and provides data systems and professional services that enable teachers to use data to assess student progress and deliver individualized instructions. News Corporation was f! ounded in 1922 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Peter Graham]

  The Q3 2014 earnings report for mid cap online real estate information stock Zillow Inc (NASDAQ: Z), a peer of small cap Move Inc (NASDAQ: MOVE) which News Corp (NASDAQ: NWSA) is acquiring and small cap Trulia Inc (NYSE: TRLA) which Zillow is also acquiring, is scheduled for after the market's close on Wednesday (November 5th). Aside from the Zillow Inc earnings report, it should be said that Move Inc reported Q2 2014 earnings on July 29th (revenue rose 7% to $61.3M, average monthly unique users of realtor.com®'s web and mobile sites grew 18% to 31.2M and Non-GAAP Loss Per Share was $0.03 per diluted share verses Non-GAAP Earnings Per Share of $0.11) and Trulia Inc reported Q3 2014 earnings on October 29th (total revenue rose 67% to $67.1M along with an adjusted net loss of $2.8 million, or $0.08 per share on a basic and diluted basis, compared with adjusted net income of $9.1 million, or $0.26 and $0.24 per share on a basic and diluted basis, respectively). The acquis ition of Move Inc and Trulia Inc though (assuming the Federal Trade Commission approves the deal) really leaves Zillow Inc as the main publicly traded online real estate information. 

• [By Lisa Levin]

  Move (NASDAQ: MOVE) shares moved up 36.89% to $20.93. The volume of Move shares traded was 19966% higher than normal. Move agreed to be acquired by News Corp (NASDAQ: NWSA) for $21 per share, or $950 million.

• [By Lisa Levin]

  Move (NASDAQ: MOVE) shares jumped 36.82% to touch a new 52-week high of $20.92 after the company agreed to be acquired by News Corp (NASDAQ: NWSA) for $21 per share, or $950 million.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-life-sciences-companies-to-invest-in-2016.html

8 Things Apple Investors Could Have Bought With What They've Lost

After peaking at $705 last September, Apple (NASDAQ: AAPL  ) shares broke below $400 this past week for the first time since December 2011. That $305 per share loss translates into $286 billion in market cap lost in a matter of months. That's an astounding amount to have evaporated in such a short period of time, mostly resulting from growth deceleration, high-end market saturation, and -- most of all -- fear.

The value that Apple investors have lost in aggregate since September could buy an awful lot of things. What could shareholders have purchased or paid for with $286 billion?

1 Microsoft and 3 Netflixes
With longtime rival Microsoft's (NASDAQ: MSFT  ) entire valuation currently under $250 billion, Apple investors could have theoretically swallowed the software giant whole with as much as they've lost. With the change left over ("can you break a 286 billion dollar bill?"), the Mac maker could have also scooped up Netflix (NASDAQ: NFLX  ) three times over just for good measure. Buying the dominant online video streamer has been entertained before.

Almost 2 International Space Stations
With development beginning in 1994, the International Space Station has cost an estimated total of $150 billion over the past 19 years to build, operate, and maintain. Only approximately $100 billion has been borne by the U.S., with other countries pitching in to help foot the bill. For $286 billion, Apple investors could have nearly financed two orbital research facilities.

14 million discouraged European workers
One of the European Union's research agencies, Eurofound, conducted a study late last year that estimated the cost of Europe's "lost generation," 14 million out-of-work and discouraged young Europeans. Aged 15 to 29, these individuals are not employed and not pursuing education and training, in part because of difficult macroeconomic conditions across the pond. The report estimates that this group altogether is costing the EU approximately 3 billion euros per week in state welfare and lost production, which translates into 153 billion euros annually. That translates into $200 billion of annual costs, well under our imaginary budget.

4 Hurricane Sandys
Easily the worst climate disaster to hit the Northeast last year was Hurricane Sandy. Economic losses, damages, and other costs related to the superstorm have been estimated at $65 billion. Apple shareholders could have covered those damages more than four times and still had money left over.

Nearly 3 iPad Minis for every person in America
With the entry-level iPad Mini starting at $329, Apple could have handed out 869 million of the devices with its market-cap losses. That would be enough for nearly three small tablets for each of the 315 million people in the U.S. today.

1 Japanese tsunami
The horrific tsunami that struck Japan in 2011 resulted in approximately $210 billion in damages. That figure covered only the first nine months of 2011 and has inevitably climbed since those estimates. With the $76 billion Apple shareholders have left over, they should be able to cover the rest, too.

8 NFLs
Forbes recently came out with its 2012 valuations of all 32 teams in the NFL. Adding up every single team's franchise value sums up to $35.4 billion, meaning Apple's lost value could cover eight entire NFLs. However, in this case, Apple could be getting something in return, since all teams combined generated an estimated $8.8 billion in revenue last year. With eight NFLs, that would be $70.4 billion in annual revenue, which still wouldn't match the iPhone business alone, which has generated $85.4 billion in sales over the past year.

371 Mona Lisas
The Mona Lisa is, of course, priceless, but that hasn't stopped people from trying to figure out its worth. The main way people have attempted to value the historic painting is through a 1962 insurance assessment, which pegged its value at $100 million at the time. Adjusting for inflation using the CPI translates that total into $770 million, making the Mona Lisa probably the most valuable painting in the world. Even so, Apple shareholders could theoretically purchase 371 of Leonardo Da Vinci's timeless masterpiece.

There's more where that came from
Of course, the list of things that $286 billion could pay for is well beyond the scope of this article. If Apple falls further, its market cap losses from the peak could easily approach or top $300 billion. What would you buy with what Apple shareholders have lost?

Can Apple ever recover all or some of its market-cap losses? That's a key question on the minds of every Apple shareholder right now, and The Motley Fool hopes to answer it in our new premium research service on Apple. Senior technology analyst Eric Bleeker, CFA, and I have produced numerous extensive reports on a wide range of topics, all of which dig into Apple's core fundamentals. Get started by clicking here.

Top 10 Railroad Companies For 2016

Top 10 Railroad Companies For 2016: GSI Group Inc.(GSIG)

GSI Group Inc. designs, develops, manufactures, and sells laser-based solutions, laser scanning devices, and precision motion and optical control technologies worldwide. The company?s Laser Products segment provides lasers and laser-based systems for photonics-based applications, such as cutting, welding, marking, engraving, micro-machining, and scientific research. Its Precision Motion and Technologies segment designs, manufactures, and markets air bearing spindles, encoders, thermal printers, laser scanning devices, and light and color measurement systems to original equipment manufacturers. The company?s Semiconductor Systems segment offers laser based production systems for semiconductor, microelectronics, and electronics manufacturing. This segment?s products comprise WaferRepair for dynamic random access memory, flash memory chips, and LCDs; WaferMark for silicon suppliers and integrated circuit factories; and WaferTrim and Circuit Trim for analog and mixed signal se nsor and chip resistor devices, as well as for resistor devices. The company sells its products primarily through direct sales force, resellers, distributors, and system integrators. It serves industrial, electronics, automotive, medical, packaging, aerospace, scientific, semiconductor, lighting, military, and motion picture markets. The company was formerly known as GSI Lumonics Inc. and changed its name to GSI Group Inc. in 2005. GSI Group Inc. was founded in 1970 and is based in Bedford, Massachusetts.

Advisors' Opinion:

• [By Eric Volkman]

  Electro Scientific Industries (NASDAQ: ESIO  ) has a new division under its corporate wing. The company has inked a definitive agreement to purchase the semiconductor systems unit of GSI Group (NASDAQ: GSIG  ) . The terms of the deal were not disclosed.

source from Top Stocks To Buy For 2015:http://www.topsto! cksforum.com/top-10-railroad-companies-for-2016.html

10 Best Clean Energy Stocks To Own Right Now

Last week, the Cleantech Group and�Heslin Rothenberg Farley & Mesiti P.C. co-released their 2013 Clean Energy Patent Growth Index, which tracks clean energy patents issued by the United States Patent and Trademark Office. The index is meant to�depict a trajectory of innovative activity in the clean energy sector.�Among its highlights:�

Solar, with 965 patents, was the No. 1 technology, overtaking fuel cells. And each year, the technology commands a greater share of patent activity:

Image credit: Clean Energy Patent Growth Index.

The United States was, by far, the No. 1 awarded country, with 556 of those 965 patents (56%). The United States' proportion of solar patents (56%) outsized its proportion of non-solar clean energy patents (45% ex-solar). Japan, projected to be 2014's No. 2 solar market, came in second with 107 patents (17%) awarded.� China, 2014's No. 1 projected solar market, amassed just 18 patents in 5th place.� Germany, to which the solar industry owes much for its rate of advancement, placed 4th.

Potential home-court advantage aside, the numbers indicate the U.S. is and will continue to be the hub for solar innovation, which is why SunPower (NASDAQ: SPWR  ) and First Solar (NASDAQ: FSLR  ) warrant consideration for any solar investor. SunPower, which touts the highest-efficiency commercially available panels has long demonstrated its R&D prowess. In 2013, SunPower took home second solar prize with 28 patents awarded (compared to 10 for First Solar).�

Top 10 Recreation Companies To Invest In Right Now: Opus International Consultants Ltd (OIC)

Opus International Consultants Limited is a supplier of multidisciplinary consultancy and project management services across a range of disciplines including, civil, mechanical and electrical engineering, and planning, environmental, architectural and property management. The Company operates in four segments: New Zealand, United Kingdom, Australia and Canada. Services supplied support asset development and asset management activities of the Company�� clients. Asset management services include property management and asset maintenance services predominantly using our engineering and environmental specialists. Asset development services include civil, mechanical and electrical engineering, planning, environmental and architectural work. Effective September 3, 2013, Opus International Consultants Ltda majority-owned unit of Opus Group Bhd acquired Stewart, Weir & Co Ltd. Advisors' Opinion:

• [By John McCamant]

  Nektar Therapeutics (NKTR) is expected to get FDA approval this year for its lead drug naloxegol, a once-a-day pill for opioid-induced constipation (OIC). The drug is licensed to AstraZeneca. NKTR will receive up to $245 million in milestone payments, plus royalties.

10 Best Clean Energy Stocks To Own Right Now: NEC Corp (NIPNF)

NEC Corporation is a diversified company. The Information Technology (IT) Solution segment provides system integration, supporting, outsourcing and cloud services, servers, mainframes, super computers, wireless access devices and software. Carrier Network segment provides backbone network system, network access and operation support system, among others. Social Infrastructure segment provides broadcasting video system, control system, transportation and public system, fire and disaster prevention system, and others. Personal Solution segment provides smart phones, cellular phones, corporate computers, tablet terminals, mobile and wireless routers, and Internet service and display solution. The Others segment provides smart energy solution, electronic components and lighting fixtures. On October 1, 2013, it transferred 45% stake in NEC TOPPAN CIRCUIT SOLUTIONS, INC. to KYOCERA CORP, and sold all shares in NEC Magnus Communications Ltd. to NEC Networks & System Integration Corporation. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japan's Nikkei Average (JP:NIK) traded 0.5% higher in the early minutes Tuesday, extending the previous day's 0.9% advance, with the market getting some support from overnight gains for U.S. shares and a slightly weaker yen (dollar at 楼101.56 vs. 楼101.40 at Monday's open). Among the gainers, Toshiba Corp. (JP:6502) (TOSYY) rose 1.7%, Hitachi Ltd. (JP:6501) (HTHIF) gained 1.5%, NEC Corp. (JP:6701) (NIPNF) improved by 2.5%, Bridgestone Corp. (JP:5108) (BRDCF) added 2.7% to extend gains over the past couple weeks following the company's purchase of U.S.-based Masthead Industries, and Mitsubishi Heavy Industries Ltd. (JP:7011) (MHVYF) traded 1.1% higher as a Wall Street Journal report said the industrial major's Mitsubishi Aircraft unit had reached a tentative deal to sell 40 jets for the planned revival of defunct U.S. carrier Eastern Air Lines Group Inc. Auto makers were firmer as well, with Nissan Motor Co. (JP:7201) (NSANY) up 1.3%, Toyota Motor Corp. (JP:7203) (TM) up 0.5%, and Honda Motor Co. (JP:7267)

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks slipped early Monday, with the Nikkei Stock Average (JP:NIK) down 0.1% at 14,298.17, and the Topix dropping 0.4%. Singapore-traded lead futures for the Nikkei Average had suggested a 0.8% gain for the index, but the indicator fell after the Cabinet Office reported fourth-quarter economic growth of 0.3%, flat from the previous quarter and below expectations in separate Reuters and Wall Street Journal/Nikkei surveys. The disappointing economic data also pushed the yen higher, weighing on some exporters, with Panasonic Corp. (JP:6752) (PCRFF) down 1.8%, NEC Corp. (JP:6701) (NIPNF) off 1.3%, and Sony Corp. (JP:6758) (SNE) down 0.7% after S&P downgraded the firm's credit rating to BBB- from BBB with a negative outlook. Shares of Internet retailer Rakuten Inc. (JP:4755) (RKUNF) dropped 12% after announcing plans to buy online messaging and telecom firm Viber Media Inc. for $900 million as well as posting below-consensus full-year profit. Banks were broadly lower, with Mizuho Financial Group Inc. (JP:8411) (MFG) off 1% and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) off 1.1%, though Daiwa Securities Group Inc. (JP:8601)

10 Best Clean Energy Stocks To Own Right Now: Tauriga Sciences Inc (TAUG)

Tauriga Sciences, Inc., formerly Immunovative, Inc., incorporated on April 18, 2001, is a development-stage company. The Company along with Constellation Diagnostics, Inc. (Constellation) focuses on establishing a joint venture partnership to develop and commercialize a imaging-based diagnostic technology for use in predictive and preventative oncology.

The Company has rights to commercialize AlloStim and AlloVax. As of March 31, 2013 the Company did not have any revenues.

Advisors' Opinion:

• [By Peter Graham]

  Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:

10 Best Clean Energy Stocks To Own Right Now: NYSE Euronext Inc.(NYX)

NYSE Euronext, through its subsidiaries, operates securities exchanges. It operates various stock exchanges, including the New York Stock Exchange (NYSE), NYSE Arca, Inc., and NYSE Amex LLC in the United States; and five European-based exchanges that comprise Euronext N.V. ? the Paris, Amsterdam, Brussels, and Lisbon stock exchanges, as well as the NYSE Liffe derivatives markets in London, Paris, Amsterdam, Brussels, and Lisbon. The company?s Derivatives segment provides access to trade execution in derivatives products, options, and futures; offers clearing services for derivative products; and sells and distributes market data and related information. NYSE Euronext?s Cash Trading and Listings segment engages in offering access to trade execution in cash trading and settlement of transactions in European markets; obtaining new listings and servicing existing listings; selling and distributing market data and related information; and providing regulatory services. Its Info rmation Services and Technology Solutions segment operates sell side and buy side connectivity networks for its markets and for other market centers, and market participants in the United States, Europe, and Asia; provides trading and information technology software and solutions; sells and distributes market data and related information to data subscribers for proprietary data products; and offers asset management services, and consultancy services to exchanges and liquidity centers. The company is headquartered in New York, New York.

Advisors' Opinion:

• [By Nick Taborek]

  NYSE Euronext (NYX) added 0.7 percent to $41.70. The U.S. exchange operator being bought by IntercontinentalExchange Inc. reported earnings that beat estimates as revenue from derivatives trading rose and costs fell.

• [By Nina Mehta]

  CEOs of the three largest U.S. stock market operators told the SEC on April 9 that it�� time to drive more trading back toward exchanges and away from brokers. NYSE Euronext (NYX)�� Duncan Niederauer, along with Bob Greifeld of Nasdaq OMX Group Inc. (NDAQ) and Joe Ratterman of Bats Global Markets Inc., said too much off- exchange activity hurts the so-called price discovery process, making prices less reflective of buy and sell interest, according to a presentation published on the SEC website in connecting with the meeting.

• [By Anna Prior]

  IntercontinentalExchange Inc.(ICE) and NYSE Euronext sa(NYX)id Friday they had received the necessary regulatory approvals to close their deal. ICE’s $9.4 billion acquisition of NYSE will close Wednesday, the companies said.

10 Best Clean Energy Stocks To Own Right Now: Synovus Financial Corp.(SNV)

Synovus Financial Corp., a diversified financial services and bank holding company, provides commercial and retail banking, financial management, insurance, and mortgage services in Georgia, Alabama, South Carolina, Florida, and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment, and other retail loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet based banking services; and bank credit card services, including mastercard and visa services. The company?s commercial banking services comprise cash management and asset management services, capital markets services, and institutional trust services, as well as commercial, financial, and real estate loans. It also provides various other financial services, which include the portfolio management for fixed-income securities, investment banking, the execution of securities transac tions as a broker/dealer, and the provision of individual investment advice on equity and other securities; trust services; mortgage services; and financial planning services. Synovus Financial Corp. was founded in 1888 and is headquartered in Columbus, Georgia.

Advisors' Opinion:

• [By Robert Eberhard]

  Synovus Financial (NYSE: SNV  ) throws its hat into the earnings ring early Tuesday, and investors are facing a big question: Will CEO Kessel D. Stelling and crew deliver good news? Or should investors be wary of less than impressive results?

• [By Selena Maranjian]

  Caxton Associates reduced its stake in lots of companies, including Georgia-based Synovus Financial (NYSE: SNV  ) . Synovus has been posting strong return-on-equity (ROE) numbers. In May, it acquired $54 million in deposits from the failed Sunrise Bank. Bears worry about the bank's significant residential real estate business and the current low interest rate environment. It has also been working to pay off its TARP obligations.

• [By John Maxfield]

  Given that you clicked on this article, it seems safe to assume you either own stock in Synovus Financial (NYSE: SNV  ) or are considering buying shares in the near future. If so, then you've come to the right place. The table below reveals the nine most critical numbers that investors need to know about Synovus stock before deciding whether to buy, sell, or hold it.

• [By Amanda Alix]

  Large regional bank Synovus Financial (NYSE: SNV  ) has released its second-quarter earnings report, a week earlier�than previously stated. The report contained much good news for the troubled bank, but the early release was likely timed to coincide with an exciting announcement: The bank also revealed that it has a plan to finally repay its nearly $1 billion portion�of Troubled Asset Relief Program funds.

10 Best Clean Energy Stocks To Own Right Now: Attitude Drinks Inc (ATTD)

Attitude Drinks Incorporated (Attitude), incorporated on May 10, 1988, is a brand-development company. The Company focuses on the non-alcoholic single serving beverage business, developing and marketing of milk based products in two segments: sports recovery and functional dairy. The Company does not directly manufacture its products but instead outsources the manufacturing process to third party packers.

Attitude has developed its second product, which is branded as Phase III Recovery is a milk-based protein drink which is available in chocolate and vanilla flavors. The Company�� co-packer for its dairy based product is O-AT-KA Milk Products Cooperative, Inc. in Batavia, New York. This product contains 35 grams of protein that are inherent in filtered milk. The product is packaged as a retort-processed shelf stable dairy-based 100% milk-based sports recovery drink in both chocolate and vanilla flavors.

The Company competes with The Coca-Cola Company and Pepsico Inc.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Attitude Drinks Inc (OTCMKTS: ATTD), Axiologix, Inc (OTCMKTS: AXLX) and Unisource Corporation (OTCMKTS: USRC) have all been getting some attention lately in investment emails or investor alerts thanks in part to paid promotions. And while there is nothing wrong with properly disclosed paid promotions or investor relations activity, such activity can backfire on unwary investors or traders. With that in mind, here is a closer look at all three small cap stocks to help you decide whether they are truly hot or not:

10 Best Clean Energy Stocks To Own Right Now: Burlington Stores Inc (BURL)

Burlington Stores, Inc., incorporated on February 13, 2013, is a national off-price retailer of branded apparel, operating 503 stores, inclusive of an Internet store, in 44 states and Puerto Rico. The Company offers its merchandise using an Every Day Low Price (EDLP) model with savings up to 60-70% off department and specialty store regular prices. It provides its customers with a selection of fashionable branded product in women�� ready-to-wear apparel, menswear, youth apparel, baby products, footwear, accessories, home goods and coats. The Company merchandise from over 3,500 vendors, with a focus on nationally-recognized brands. This vendor breadth provides its customers with a treasure hunt experience of searching for great brands at great value.

The Company�� average store size is approximately 80,000 square feet, which is two to three times the size of its off-price competitors��stores. Its larger store size has allowed the Company to offer more categories and substantially more breadth in each product category than its off-price competitors and to establish ourselves as a destination for select categories, including coats, youth and baby, special-occasion dresses and men�� tailored apparel.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Burlington Stores (NYSE: BURL) shares shot up 15.02 percent to $29.79 on Q4 results. Burlington Stores reported its Q4 earnings of $1.07 per share, versus analysts' estimates of $1.03 per share.